» Articles » PMID: 24068266

Contribution of Flow-volume Curves to the Detection of Central Airway Obstruction

Overview
Journal J Bras Pneumol
Specialty Pulmonary Medicine
Date 2013 Sep 27
PMID 24068266
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the sensitivity and specificity of flow-volume curves in detecting central airway obstruction (CAO), and to determine whether their quantitative and qualitative criteria are associated with the location, type and degree of obstruction.

Methods: Over a four-month period, we consecutively evaluated patients with bronchoscopy indicated. Over a one-week period, all patients underwent clinical evaluation, flow-volume curve, bronchoscopy, and completed a dyspnea scale. Four reviewers, blinded to quantitative and clinical data, and bronchoscopy results, classified the morphology of the curves. A fifth reviewer determined the morphological criteria, as well as the quantitative criteria.

Results: We studied 82 patients, 36 (44%) of whom had CAO. The sensitivity and specificity of the flow-volume curves in detecting CAO were, respectively, 88.9% and 91.3% (quantitative criteria) and 30.6% and 93.5% (qualitative criteria). The most prevalent quantitative criteria in our sample were FEF50%/FIF50% ≥ 1, in 83% of patients, and FEV1/PEF ≥ 8 mL · L(-1) · min(-1), in 36%, both being associated with the type, location, and degree of obstruction (p < 0.05). There was concordance among the reviewers as to the presence of CAO. There is a relationship between the degree of obstruction and dyspnea.

Conclusions: The quantitative criteria should always be calculated for flow-volume curves in order to detect CAO, because of the low sensitivity of the qualitative criteria. Both FEF50%/FIF50% ≥ 1 and FEV1/PEF ≥ 8 mL · L(-1) · min(-1) were associated with the location, type and degree of obstruction.

Citing Articles

The Clinical Utility of Pulmonary Function Tests in the Diagnosis and Characterization of Central Airway Obstruction: A Narrative Review.

Ampazis D, Vlachakos V, Anagnostopoulos N, Tzouvelekis A, Sampsonas F J Clin Med. 2024; 13(21).

PMID: 39518438 PMC: 11546877. DOI: 10.3390/jcm13216299.


Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.

Graham B, Steenbruggen I, Miller M, Barjaktarevic I, Cooper B, Hall G Am J Respir Crit Care Med. 2019; 200(8):e70-e88.

PMID: 31613151 PMC: 6794117. DOI: 10.1164/rccm.201908-1590ST.


Malignant central airway obstruction.

Mudambi L, Miller R, Eapen G J Thorac Dis. 2017; 9(Suppl 10):S1087-S1110.

PMID: 29214067 PMC: 5696549. DOI: 10.21037/jtd.2017.07.27.


Functional changes are associated with tracheal structural abnormalities in patients with acromegaly.

Camilo G, Guimaraes F, Mogami R, Faria A, Melo P, Lopes A Arch Med Sci. 2016; 12(1):78-88.

PMID: 26925121 PMC: 4754368. DOI: 10.5114/aoms.2016.57582.

References
1.
Brookes G, Fairfax A . Chronic upper airway obstruction: value of the flow volume loop examination in assessment and management. J R Soc Med. 1982; 75(6):425-34. PMC: 1437964. DOI: 10.1177/014107688207500611. View

2.
Herzog H, Keller R, ALLGOWER M . Special methods of diagnosing and treating obstructive diseases of the central airways. Chest. 1971; 60(1):49-67. DOI: 10.1378/chest.60.1.49. View

3.
Das A, Davanzo L, Poiani G, Zazzali P, Scardella A, Warnock M . Variable extrathoracic airflow obstruction and chronic laryngotracheitis in Gulf War veterans. Chest. 1999; 115(1):97-101. DOI: 10.1378/chest.115.1.97. View

4.
Kvale P, Selecky P, Prakash U . Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3 Suppl):368S-403S. DOI: 10.1378/chest.07-1391. View

5.
Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R . Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-68. DOI: 10.1183/09031936.05.00035205. View